Bergman W - Search Results

1

The efficacy of histopathological criteria required for diagnosing dysplastic naevi.

Steijlen PM, Bergman W, Hermans J, Scheffer E, Van Vloten WA, Ruiter DJ. Steijlen PM, et al. Among authors: bergman w. Histopathology. 1988 Mar;12(3):289-300. doi: 10.1111/j.1365-2559.1988.tb01943.x. Histopathology. 1988. PMID: 3366444

2

Melanocytic atypia in dysplastic nevi. Immunohistochemical and cytophotometrical analysis.

Bergman W, Ruiter DJ, Scheffer E, van Vloten WA. Bergman W, et al. Cancer. 1988 Apr 15;61(8):1660-6. doi: 10.1002/1097-0142(19880415)61:8<1660::aid-cncr2820610825>3.0.co;2-x. Cancer. 1988. PMID: 3349425

3

On naevi and melanomas in dysplastic naevus syndrome patients.

Crijns MB, Bergman W, Berger MJ, Hermans J, Sober AJ. Crijns MB, et al. Among authors: bergman w. Clin Exp Dermatol. 1993 May;18(3):248-52. doi: 10.1111/j.1365-2230.1993.tb02179.x. Clin Exp Dermatol. 1993. PMID: 8348718

4

[Dysplastic nevi and the risk of melanoma: a guideline for patient care. Nederlandse Melanoom Werkgroep van de Vereniging voor Integrale Kankercentra].

Bergman W, van Voorst Vader PC, Ruiter DJ. Bergman W, et al. Ned Tijdschr Geneeskd. 1997 Oct 18;141(42):2010-4. Ned Tijdschr Geneeskd. 1997. PMID: 9550752 Dutch.

5

The familial dysplastic nevus syndrome. Natural history and the impact of screening on prognosis. A study of nine families in the Netherlands.

Vasen HF, Bergman W, van Haeringen A, Scheffer E, van Slooten EA. Vasen HF, et al. Among authors: bergman w. Eur J Cancer Clin Oncol. 1989 Feb;25(2):337-41. doi: 10.1016/0277-5379(89)90027-8. Eur J Cancer Clin Oncol. 1989. PMID: 2702987

6

Multiple primary melanomas.

Stam-Posthuma JJ, van Duinen C, Scheffer E, Vink J, Bergman W. Stam-Posthuma JJ, et al. Among authors: bergman w. J Am Acad Dermatol. 2001 Jan;44(1):22-7. doi: 10.1067/mjd.2001.110878. J Am Acad Dermatol. 2001. PMID: 11148472

7

Multiple primary melanomas in a patient with familial-type DNS during clomiphene-induced pregnancy.

Kuppens E, Bergman W, Welvaart K, Bruijn JA, Scheffer E. Kuppens E, et al. Among authors: bergman w. Melanoma Res. 1992 May;2(1):71-4. doi: 10.1097/00008390-199205000-00010. Melanoma Res. 1992. PMID: 1643427

8

Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.

Ruiter DJ, Bergman W, Welvaart K, Scheffer E, van Vloten WA, Russo C, Ferrone S. Ruiter DJ, et al. Among authors: bergman w. Cancer Res. 1984 Sep;44(9):3930-5. Cancer Res. 1984. PMID: 6204749

9

Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi.

Ruiter DJ, Dingjan GM, Steijlen PM, van Beveren-Hooyer M, de Graaff-Reitsma C, Bergman W, van Muijen GN, Warnaar SO. Ruiter DJ, et al. Among authors: bergman w. J Invest Dermatol. 1985 Jul;85(1):4-8. doi: 10.1111/1523-1747.ep12274479. J Invest Dermatol. 1985. PMID: 3891875 Free article.

10

PUVA keratosis. A clinical and histopathologic entity associated with an increased risk of nonmelanoma skin cancer.

van Praag MC, Bavinck JN, Bergman W, Rosendaal FR, Mommaas AM, Bruynzeel I, Scheffer E, Vermeer BJ, Bruijn JA. van Praag MC, et al. Among authors: bergman w. J Am Acad Dermatol. 1993 Mar;28(3):412-7. J Am Acad Dermatol. 1993. PMID: 8445056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

151 results

Search Page